Northland Securities Weighs in on Astera Labs Q1 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Investment analysts at Northland Securities increased their Q1 2026 EPS estimates for shares of Astera Labs in a report released on Wednesday, February 11th. Northland Securities analyst G. Richard now forecasts that the company will post earnings of $0.32 per share for the quarter, up from their prior estimate of $0.24. Northland Securities has a “Outperform” rating and a $195.00 price objective on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $0.34 per share. Northland Securities also issued estimates for Astera Labs’ Q2 2026 earnings at $0.33 EPS, Q3 2026 earnings at $0.35 EPS, Q4 2026 earnings at $0.35 EPS, FY2026 earnings at $1.35 EPS, Q1 2027 earnings at $0.38 EPS and FY2027 earnings at $2.11 EPS.

ALAB has been the topic of a number of other research reports. Roth Mkm raised their target price on Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Citigroup lowered their price target on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, January 21st. Finally, Needham & Company LLC increased their target price on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Fourteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $192.89.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $129.32 on Monday. Astera Labs has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a market cap of $21.84 billion, a price-to-earnings ratio of 106.00, a PEG ratio of 2.54 and a beta of 1.51. The firm’s 50-day simple moving average is $164.09 and its 200 day simple moving average is $174.83.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The business’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period last year, the firm earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS.

Institutional Investors Weigh In On Astera Labs

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in Astera Labs by 29.6% during the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. Amundi raised its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Rafferty Asset Management LLC purchased a new position in shares of Astera Labs during the 3rd quarter valued at $209,599,000. BNP Paribas Financial Markets lifted its position in shares of Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after buying an additional 960,899 shares during the last quarter. Finally, 1832 Asset Management L.P. lifted its position in shares of Astera Labs by 151.4% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 150,000 shares of the stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 12.50% of the stock is owned by insiders.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.